Allarity Therapeutics, Inc. (ALLR) is the 252nd largest of 300 Pharmaceuticals companies by market capitalisation, at 20.21 Mn, behind Firefly Neuroscience, Inc. at 21.81 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 443.31 Bn | 70.19 | 6.89 | 436.74 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.74 Bn | 115.10 | 5.48 | 357.60 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.46 Bn | 9.25 | 3.88 | 258.77 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.33 Bn | 11.23 | 0.98 | 44.95 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.79 Bn | -24.76 | — | 43.79 Bn |
| 8 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.23 Bn | 15.65 | 4.34 | 20.69 Bn |
| 9 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 10 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 11 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.22 Bn | 16.17 | 3.31 | 13.60 Bn |
| 12 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | 16.98 | 6.00 | 13.78 Bn |
| 13 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 14 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.32 Bn | -37.78 | 107.81 | 10.63 Bn |
| 15 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.89 Bn | -70.84 | 14.02 | 10.57 Bn |
| 16 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.79 Bn | -13.35 | 144.68 | 8.62 Bn |
| 17 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 18 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 19 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.96 Bn | -47.63 | — | 8.96 Bn |
| 20 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.56 | 4.54 | 6.92 Bn |
| 21 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.87 | 10.50 | 6.09 Bn |
| 22 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.15 Bn | 0.08 | — | 6.15 Bn |
| 23 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 24 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.71 | 32.00 | 5.64 Bn |
| 25 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.76 Bn | 12.50 | 4.18 | 3.80 Bn |
| 26 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.69 | — | 4.67 Bn |
| 27 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -11.83 | — | 4.18 Bn |
| 28 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.13 Bn | 11.63 | 3.10 | 3.91 Bn |
| 29 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.48 | — | 4.00 Bn |
| 30 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -45.13 | — | 3.80 Bn |
| 32 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -76.58 | 5.93 | 3.14 Bn |
| 33 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 34 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -10.83 | 394.49 | 2.81 Bn |
| 35 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.54 | 0.06 | -3.19 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -61.67 | — | 2.60 Bn |
| 37 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | -7.41 | — | 2.59 Bn |
| 38 | BEIGF | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 39 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.71 | 3.10 | 2.07 Bn |
| 40 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.50 | 2.51 | 1.60 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.11 | 13.44 | 2.28 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.18 Bn | -41.21 | — | 1.87 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.70 | 6.76 | 1.66 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | 170.39 | 16.23 | 1.60 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.91 | 3.01 | 0.97 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.70 | — | 1.43 Bn |
| 47 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 48 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.52 | 3.97 | 1.21 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -30.70 | 1.98 | 0.86 Bn |
| 50 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -5.32 | — | 1.09 Bn |
| 51 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.95 | 1.08 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 54 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -11.54 | — | 0.73 Bn |
| 55 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -48.72 | — | 0.91 Bn |
| 56 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.91 | 9.10 | 0.66 Bn |
| 57 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 15.72 | 0.93 | 0.60 Bn |
| 58 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.42 | 3.04 | 0.54 Bn |
| 59 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.24 | 5.24 | 0.49 Bn |
| 60 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -38.15 | 5.90 | 0.65 Bn |
| 61 | IVEVF | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 62 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.19 | 11.84 | 0.54 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.07 | 1.70 | 0.38 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -16.41 | 1.78 | 0.52 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -17.80 | — | 0.54 Bn |
| 67 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.37 | 334.91 | 0.41 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.36 | 4.46 | 0.38 Bn |
| 69 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.99 | 28.37 | 0.25 Bn |
| 70 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.43 | — | 0.26 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.86 | 11.34 | 0.42 Bn |
| 73 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -52.78 | — | 0.41 Bn |
| 74 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 75 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 76 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.47 | 0.15 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.02 | — | 0.30 Bn |
| 78 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.67 | 0.38 | 0.15 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -1.94 | — | 0.27 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.70 | 1.18 | 0.10 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.33 | 7.32 | 0.21 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -55.91 | 3.00 | 0.18 Bn |
| 86 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.59 | — | 0.20 Bn |
| 87 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -38.89 | 8.50 | 0.20 Bn |
| 88 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.17 | 14.71 | 0.16 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 90 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -29.09 | — | 0.19 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -1.42 | — | 0.12 Bn |
| 92 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 93 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.19 | 7.19 | 0.15 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.33 | — | 0.13 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -4.22 | — | 0.10 Bn |
| 96 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.48 | 3.60 | 0.10 Bn |
| 97 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.55 | — | 0.03 Bn |
| 98 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.49 | — | 0.10 Bn |
| 99 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.86 | 3.05 | 0.09 Bn |
| 100 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.47 | — | 0.09 Bn |
| 101 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.99 | — | 0.09 Bn |
| 102 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.67 | 100.93 | 0.09 Bn |
| 103 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.57 | 0.06 Bn |
| 104 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.07 Bn |
| 105 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.20 | — | -0.01 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 107 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 108 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 115.53 | — | 0.03 Bn |
| 109 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.30 | 0.96 | -0.01 Bn |
| 110 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.25 | 0.33 | -0.02 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.95 | — | 0.05 Bn |
| 112 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.36 | 217.73 | 0.05 Bn |
| 113 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.41 | — | 0.04 Bn |
| 114 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.84 | — | 0.04 Bn |
| 115 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.85 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.13 | -0.08 Bn |
| 117 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.34 | 2.90 | 0.02 Bn |
| 118 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.51 | — | 0.03 Bn |
| 119 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.01 | 8.02 | 0.03 Bn |
| 120 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 121 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.85 | 77.46 | 0.03 Bn |
| 122 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.20 | 50.30 | 0.00 Bn |
| 123 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -2.97 | — | 0.03 Bn |
| 124 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -132.69 | 7.51 | 0.02 Bn |
| 125 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | 0.40 | 0.00 Bn |
| 126 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.72 | — | 0.02 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.67 | 808.26 | 0.02 Bn |
| 128 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.28 | 0.45 | 0.02 Bn |
| 129 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.56 | — | 0.01 Bn |
| 130 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.67 | — | 0.02 Bn |
| 131 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.41 | — | 0.02 Bn |
| 132 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.17 | 0.02 Bn |
| 133 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 135 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.38 | -9.36 | -0.01 Bn |
| 136 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.74 | — | 0.01 Bn |
| 137 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 138 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 139 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.00 Bn |
| 140 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 141 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.41 | — | 0.01 Bn |
| 142 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.32 | — | 0.01 Bn |
| 143 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.93 | 1,256.38 | 0.00 Bn |
| 144 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.30 | — | 0.00 Bn |
| 146 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 147 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 148 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 5.93 | 0.00 Bn |
| 149 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 150 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 151 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 152 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 153 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.76 | 0.00 Bn |
| 154 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 155 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 156 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 157 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.01 | -0.01 Bn |
| 158 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 159 | CINGW | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 225.48 Bn | 32.03 | 4.87 | 221.41 Bn |
| 163 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 183.04 Bn | 33.74 | 3.93 | 177.44 Bn |
| 164 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 165 | DHR | Danaher Corp /De/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 144.42 Bn | 36.20 | 5.75 | 140.08 Bn |
| 166 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 167 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 125.02 Bn | 39.59 | 11.33 | 119.81 Bn |
| 168 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 117.84 Bn | 22.36 | 3.14 | 109.02 Bn |
| 169 | CAH | Cardinal Health Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 56.55 Bn | 33.17 | 0.22 | 51.69 Bn |
| 170 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.48 Bn | 52.52 | 2.13 | 48.62 Bn |
| 171 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 172 | A | Agilent Technologies, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 40.86 Bn | 28.38 | 5.54 | 39.11 Bn |
| 173 | IDXX | Idexx Laboratories Inc /De | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 40.69 Bn | 35.70 | 8.94 | 40.49 Bn |
| 174 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.70 Bn | 52.41 | 3.13 | 32.24 Bn |
| 175 | ILMN | Illumina, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 30.97 Bn | 37.54 | 6.89 | 29.80 Bn |
| 176 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 177 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.54 Bn | 14.41 | 1.39 | 27.44 Bn |
| 178 | MDLN | Medline Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 29.24 Bn | 28.30 | 1.02 | 26.56 Bn |
| 179 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 180 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 181 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.01 Bn | 31.84 | 3.94 | 16.64 Bn |
| 182 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.38 Bn | 40.38 | 4.09 | 13.77 Bn |
| 183 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 13.85 Bn | 58.30 | 4.76 | 12.83 Bn |
| 184 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.66 Bn | 550.61 | 1.14 | 10.51 Bn |
| 185 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.34 Bn | 52.34 | 2.92 | 12.20 Bn |
| 186 | TECH | BIO-TECHNE Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 11.27 Bn | 61.97 | 9.28 | 11.01 Bn |
| 187 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.15 | 17.26 | 10.46 Bn |
| 188 | BIO | Bio-Rad Laboratories, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 10.11 Bn | 45.45 | 3.90 | 8.49 Bn |
| 189 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.05 Bn | -26.35 | — | 9.29 Bn |
| 190 | BRKR | Bruker Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.30 Bn | -77.68 | 2.37 | 8.09 Bn |
| 191 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 192 | OKLO | Oklo Inc. | secondary | U-03 | Power Generation | UG-01 | 7.53 Bn | -49.31 | 6,314.48 | 7.53 Bn |
| 193 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.56 Bn | 23.84 | 4.22 | 5.97 Bn |
| 194 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.37 Bn | -20.43 | 2.00 | 6.17 Bn |
| 195 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 196 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 197 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.51 Bn | 35.10 | 3.86 | 5.40 Bn |
| 198 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 199 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.89 Bn | -17.03 | — | 4.89 Bn |
| 200 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 201 | MIR | Mirion Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 4.07 Bn | 159.02 | 3.97 | 3.65 Bn |
| 202 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | -7.94 | 1,126.80 | 4.06 Bn |
| 203 | HTFL | Heartflow, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 4.04 Bn | -166.44 | 19.90 | 3.66 Bn |
| 204 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 205 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.79 | 30.64 | 2.88 Bn |
| 206 | VCYT | Veracyte, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.51 Bn | 30.68 | 6.25 | 3.21 Bn |
| 207 | GRAL | GRAIL, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.36 Bn | -8.57 | 21.34 | 2.49 Bn |
| 208 | OSIS | Osi Systems Inc | secondary | I-02 | Aerospace and Defense | IG-01 | 3.26 Bn | 21.09 | 1.83 | 2.90 Bn |
| 209 | SXI | Standex International Corp/De/ | secondary | I-04 | Machinery | IG-02 | 3.24 Bn | 25.22 | 3.64 | 3.06 Bn |
| 210 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -10.96 | 593.06 | 2.44 Bn |
| 211 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.57 | 79.61 | 2.48 Bn |
| 212 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -14.90 | 6.24 | 2.10 Bn |
| 213 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.66 Bn | -22.42 | 2.03 | 2.56 Bn |
| 214 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.36 | — | 2.64 Bn |
| 215 | NEOG | Neogen Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 2.59 Bn | -365.72 | 2.98 | 2.41 Bn |
| 216 | CDNA | CareDx, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 2.57 Bn | 23.15 | 5.61 | 2.20 Bn |
| 217 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 218 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -5.95 | 4.28 | 1.94 Bn |
| 219 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -3.87 | — | 2.00 Bn |
| 220 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 2,033.16 | 2.03 Bn |
| 221 | BFLY | Butterfly Network, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.96 Bn | -26.25 | 17.52 | 1.84 Bn |
| 222 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 223 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 225 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.67 | — | 1.42 Bn |
| 226 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | 82.16 | 36.50 | 1.40 Bn |
| 227 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.40 Bn | -12.73 | 1.72 | 1.28 Bn |
| 228 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.77 | — | 1.02 Bn |
| 229 | ASST | Strive, Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 1.18 Bn | -2.97 | 4,532.77 | 1.11 Bn |
| 230 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.03 | — | 0.92 Bn |
| 231 | CBLL | Ceribell, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.93 Bn | -14.07 | 9.11 | 0.80 Bn |
| 232 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.87 Bn | — | — | 0.74 Bn |
| 233 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.89 | 95.78 | 0.79 Bn |
| 234 | VREX | Varex Imaging Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.78 Bn | 34.62 | 0.90 | 0.68 Bn |
| 235 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.70 Bn | 199.22 | 2.81 | 0.67 Bn |
| 236 | CTKB | Cytek Biosciences, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.61 Bn | -7.63 | 2.97 | 0.54 Bn |
| 237 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -340,055.90 | — | 0.60 Bn |
| 238 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,165.03 | 6.03 | 0.48 Bn |
| 239 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 240 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.41 | 22.27 | 0.22 Bn |
| 241 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 78.36 | 0.23 Bn |
| 242 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.14 | 39.23 | 0.19 Bn |
| 243 | TKNO | Alpha Teknova, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.37 Bn | -28.08 | 8.43 | 0.35 Bn |
| 244 | CATX | Perspective Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | -3.02 | — | 0.36 Bn |
| 245 | PRE | Prenetics Global Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -7.19 | 2.44 | 0.28 Bn |
| 246 | CV | CapsoVision, Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.32 Bn | -11.62 | 22.10 | 0.31 Bn |
| 247 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.28 | 7.49 | 0.27 Bn |
| 248 | MYGN | Myriad Genetics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.30 Bn | -2.67 | 0.37 | 0.19 Bn |
| 249 | NNNN | Anbio Biotechnology | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | 44.60 | 108.83 | 0.27 Bn |
| 250 | BCYC | Bicycle Therapeutics Plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -1.46 | 4.56 | 0.28 Bn |
| 251 | ACIU | AC Immune SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -5.13 | 12.56 | 0.28 Bn |
| 252 | RELL | Richardson Electronics, Ltd. | secondary | I-07 | Machinery | IG-02 | 0.25 Bn | 42.88 | 1.11 | 0.22 Bn |
| 253 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.24 Bn | — | 2,445.63 | 0.05 Bn |
| 254 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.05 | — | 0.21 Bn |
| 255 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.77 | 90.00 | 0.13 Bn |
| 256 | LUCD | Lucid Diagnostics Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.15 Bn | -2.31 | 27.21 | 0.12 Bn |
| 257 | ZSQR | Z Squared Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -7.70 | 53.11 | 0.13 Bn |
| 258 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.40 | 107.84 | 0.14 Bn |
| 259 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 1,788.24 | -0.04 Bn |
| 260 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.80 | — | 0.14 Bn |
| 261 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.11 Bn | -12.74 | 1.40 | 0.04 Bn |
| 262 | SERA | Sera Prognostics, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.10 Bn | -3.10 | 1,478.25 | 0.10 Bn |
| 263 | ICCC | Immucell Corp /De/ | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -212.32 | 3.37 | 0.08 Bn |
| 264 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.72 | — | 0.08 Bn |
| 265 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.01 | 1.21 | -0.11 Bn |
| 266 | LUNG | Pulmonx Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | — | — | 0.01 Bn |
| 267 | HYPR | Hyperfine, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | -2.28 | 4.80 | 0.03 Bn |
| 268 | RTGN | RetinalGenix Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | — | — | 0.08 Bn |
| 269 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.07 Bn | -0.08 | 3.47 | 0.06 Bn |
| 270 | RPID | Rapid Micro Biosystems, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -1.16 | 1.69 | 0.04 Bn |
| 271 | MDAI | Spectral AI, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -6.03 | 3.32 | 0.04 Bn |
| 272 | NNOX | Nano-X Imaging Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -0.64 | 3.47 | 0.01 Bn |
| 273 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.87 | 3.83 | 0.05 Bn |
| 274 | PRPO | Precipio, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.05 Bn | 150.88 | 0.79 | 0.04 Bn |
| 275 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.72 | 4.79 | 0.03 Bn |
| 276 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.04 Bn |
| 277 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -6.19 | 0.38 | 0.03 Bn |
| 278 | ARAY | Accuray Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -0.67 | 0.08 | -0.01 Bn |
| 279 | PAVM | PAVmed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -1.07 | 230.71 | 0.03 Bn |
| 280 | ADIL | Adial Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.43 | — | 0.03 Bn |
| 281 | QTEX | QTREX Quantum Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | 1.86 | 4.45 | 0.02 Bn |
| 282 | QUCY | Quantum Cyber N.V. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -1.01 | — | 0.01 Bn |
| 283 | GIPL | Global Innovative Platforms Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -36.02 | 132.88 | 0.02 Bn |
| 284 | RDPTF | Radiopharm Theranostics Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.28 | 97.58 | 0.02 Bn |
| 285 | BEAT | HeartBeam, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -1.40 | — | 0.02 Bn |
| 286 | AIFF | Firefly Neuroscience, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -2.31 | 12.13 | 0.01 Bn |
| 287 | PLSM | Pulsenmore Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | 8.23 | 13.89 | -0.01 Bn |
| 288 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.02 Bn | -1.23 | — | 0.01 Bn |
| 289 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.01 Bn | -2.05 | — | 0.01 Bn |
| 290 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.93 | 1.51 | 0.01 Bn |
| 291 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.05 | — | 0.01 Bn |
| 292 | ALRTF | ALR Technologies SG Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.55 | — | 0.01 Bn |
| 293 | ASTC | ASTROTECH Corp | secondary | I-04 | Machinery | IG-02 | 0.01 Bn | -0.90 | 12.49 | 0.01 Bn |
| 294 | ADVB | Advanced Biomed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 2.44 | — | 0.01 Bn |
| 295 | FEMY | Femasys Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.47 | 5.63 | 0.01 Bn |
| 296 | LNAI | Lunai Bioworks Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.06 | 96.04 | 0.01 Bn |
| 297 | NDRA | ENDRA Life Sciences Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.33 | — | 0.00 Bn |
| 298 | BMRA | Biomerica Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -2.17 | 1.46 | 0.01 Bn |
| 299 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -0.95 | 2.83 | 0.00 Bn |
| 300 | CDIO | Cardio Diagnostics Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.93 | 417.81 | 0.00 Bn |